LEMAITRE VASCULAR INC — Director's Dealing 2017

Jul 26, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LEMAITRE VASCULAR INC (LMAT)
CIK: 0001158895
Period of Report: 2017-07-25

Reporting Person: LeMaitre George W (Director, Chairman and CEO, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-07-25	Common Stock	M	23621	$12.57	Acquired	3416962	Direct
2017-07-25	Common Stock	M	30973	$8.66	Acquired	3447935	Direct
2017-07-25	Common Stock	M	18454	$7.34	Acquired	3466389	Direct
2017-07-25	Common Stock	M	30317	$14.13	Acquired	3496706	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-07-25	Stock Option (Right to Buy)	$12.57	M	23621	Disposed	2020-07-23	Common Stock (23621)	Direct
2017-07-25	Stock Option (Right to Buy)	$8.66	M	30973	Disposed	2019-07-24	Common Stock (30973)	Direct
2017-07-25	Stock Option (Right to Buy)	$7.34	M	18454	Disposed	2018-07-24	Common Stock (18454)	Direct
2017-07-25	Stock Option (Right to Buy)	$14.13	M	30317	Disposed	2021-07-25	Common Stock (30317)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	72030	Indirect

Footnotes

F1: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II.

F2: These shares are owned by LeMaitre Family LLC. A trust for the benefit of the Reporting Person holds a 20% membership interest in LeMaitre Family LLC. LeMaitre Family LLC is 100% owned by Peter Boland, as trustee for various trusts formed for the benefit of the children of George D. LeMaitre, the Issuer's founder, and Cornelia W. LeMaitre. LeMaitre Family LLC currently holds 360,154 shares of the Issuer's Common Stock. The Reporting Person disclaims ownership of such securities except to the extent of his pecuniary interest therein, if any, and the reporting herein of such securities shall not be construed as an admission of beneficial ownership thereof for the purposes of Section 16 or for any other purpose.

F3: This option is exercisable and vests over a five-year period at a rate of 20% on the first anniversary of the date listed in the table, and the balance vests in equal annual installments over the remaining four years, with the final vesting occurring on the 11th month after the fourth anniversary.